Category: ROOT

Are zero-tolerance policies for patient bias on the right track?

Some healthcare systems are addressing patient biases with zero-tolerance policies, but not all physicians are on board.

Memorial taps Epic-based platform for virtual care

Hollywood, Fla.-based Memorial Healthcare System has partnered with KeyCare, a virtual care company built with Epic, to power the health system’s MemorialDOCNow digital care platform.

110 hospital and health system chief medical officers to know | 2023

Becker’s Healthcare is pleased to name the “110 hospital and health system chief medical officers to know” in 2023.

Intermountain Health added to CHIME's Most Wired list

Salt Lake City-based Intermountain Health has been added to the list of the College of Healthcare Information Management Executives’ Most Wired health systems for 2022.

UW Medicine collaborates with digital health platform to treat Type 2 diabetes remotely, with AI 

Seattle-based UW Medicine is teaming up with digital platform Delve Health to improve the care of Type 2 diabetes patients through the use of remote monitoring and artificial intelligence.

Hawaii hospital asks locals to help house traveling nurses

Nurses are sparse in Hawaii — in part because the islands’ high housing costs keep them out, Hawaii News Now reported Feb. 21. 

98% of HR managers use AI to make layoff decisions

As artificial intelligence expands its footprint in the workplace, it might remove the “human” from some human resources decisions. 

MaineHealth reports reduced operating gain on back of almost $1B expenses

Portland-based MaineHealth reported operating income of $16 million as it revealed almost $1 billion in revenue for the quarter ending Dec. 31.

Senators introduce bill to expand physician-led hospitals

A proposed bill in the U.S. Senate would expand the rights of physician-owned hospitals — including some privileges that were rescinded more than a decade ago. 

How ophthalmologists feel about biosimilars

The first ophthalmologic biosimilar did not launch in the U.S. until July 2022, and some prescribers are still cautious about their uses, according to Cardinal Health’s 2023 “Biosimilars Report,” which surveyed over 350 providers in four physician spec…